申请人:AstraZeneca AB
公开号:US20040229900A1
公开(公告)日:2004-11-18
There is provided compounds of formula I,
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
41
, R
42
, R
43
R
44
, R
45
, R
46
, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
提供了一种化合物I的公式,其中R1、R2、R3、R4、R5、R6、R7、R41、R42、R43、R44、R45、R46、A和B在描述中给出了含义,这些化合物在预防和治疗心律不齐方面特别是房性和室性心律不齐方面是有用的。